Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human gene therapy.

R A Fleischman1

  • 1University of Texas Southwestern Medical Center.

The American Journal of the Medical Sciences
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Gene therapy utilizes retroviral vectors to deliver normal genes into patient stem cells, offering a potential cure for inherited genetic disorders. This innovative approach is advancing rapidly toward clinical application.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia.

Leukemia·2021
Same author

Mutations in the ligand-binding domain of the kit receptor: an uncommon site in human piebaldism.

The Journal of investigative dermatology·1996
Same author

Isolation of endothelial-like stromal cells that express Kit ligand and support in vitro hematopoiesis.

Experimental hematology·1995
Same author

Acute onset of severe autoimmune hemolytic anemia after treatment with 2-chlorodeoxyadenosine for chronic lymphocytic leukemia.

American journal of hematology·1995
Same author

From white spots to stem cells: the role of the Kit receptor in mammalian development.

Trends in genetics : TIG·1993
Same author

Southwestern Internal Medicine Conference: clinical use of hematopoietic growth factors.

The American journal of the medical sciences·1993
Same journal

Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

The American journal of the medical sciences·2026
Same journal

In Memoriam: Maurice A. Mufson, MD, MACP.

The American journal of the medical sciences·2026
Same journal

Outcomes of acute myeloid leukemia patients admitted to the intensive care unit within 100 days of allogeneic hematopoietic stem cell transplantation.

The American journal of the medical sciences·2026
Same journal

Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

The American journal of the medical sciences·2026
Same journal

Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

The American journal of the medical sciences·2026
Same journal

The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

The American journal of the medical sciences·2026
See all related articles

Area of Science:

  • Molecular genetics
  • Gene therapy
  • Retroviral vectors

Background:

  • Advances in molecular genetics enable gene transfer into somatic cells.
  • Retroviral vectors are key tools for delivering cloned human genes.
  • Hematopoietic stem cells are primary targets for correcting genetic defects.

Purpose of the Study:

  • To review the design and safety of viral vectors for gene therapy.
  • To discuss in vivo study results in animal models.
  • To explore other target cells for gene transfer.

Main Methods:

  • Utilizing retroviral vectors for gene transfer.
  • In vivo studies in mice and large animals.
  • Evaluation of safety and efficacy of gene transfer techniques.

Related Experiment Videos

Main Results:

  • Successful gene transfer into hematopoietic stem cells demonstrated.
  • Positive outcomes in preclinical animal studies.
  • Progression to initial human clinical trials.

Conclusions:

  • Gene therapy holds significant promise for treating recessive inherited disorders.
  • Viral vector technology is advancing, with safety and efficacy being paramount.
  • Medical and scientific communities show increasing acceptance of in vivo gene therapy.